Icagen, Inc. Purchase Agreements
11 Contracts & Agreements
- Asset Purchase Agreement dated as of February 11, 2020 by and between Icagen, Inc. and Adjacent Acquisition Co., LLC (Filed With SEC on February 19, 2020)
- Form of Securities Purchase Agreement by and between Icagen, Inc. and the Purchaser named therein (Filed With SEC on August 30, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on August 15, 2018)
- Form of Securities Purchase Agreement by and between Icagen, Inc. and the Purchaser named therein (Filed With SEC on April 9, 2018)
- Second Amendment to Asset Purchase and Collaboration Agreement by and between Pfizer Research Inc. and Icagen Inc (Filed With SEC on August 16, 2017)
- Securities Purchase Agreement, dated May 15, 2017, by and among Icagen, Inc., Icagen-T, Inc., and GPB Debt Holdings II, LLC (Filed With SEC on May 17, 2017)
- Amendmentto ASSET PURCHASE AND COLLABORATION AGREEMENT (Filed With SEC on July 19, 2016)
- Asset Purchase and collaboration Agreement between Icagen,Inc. and XRPRO SCIENCES, INC. DATED AS OF JUNE 26, 2015 (Filed With SEC on July 2, 2015)
- XRPRO SCIENCES, INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 7, 2015)
- CALDERA PHARMACEUTICALS, INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 29, 2013)
- FIRST AMENDMENT TO THE PURCHASE AGREEMENT July 20, 2011 (Filed With SEC on July 20, 2011)